Popular Articles

Doctors Angry About BNP Campaign Tactics, UK
Correspondence and a linked Editorial in this week"s Lancet criticise the election tactics employed by the British National Party (BNP) prior to the recent European Elections.

Transcept Pharmaceuticals Announces Expected FDA Extension Of Regulatory Review Period For Intermezzo(R)
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced that the U.S. Food and Drug Administration (FDA) has informed the company that it should expect to receive formal notice of a three month extension of the review period for the new drug application (NDA) for Intermezzo(R) (zolpidem tartrate sublingual tablet). The Intermezzo(R) NDA had been assigned a Prescription Drug User Fee Act (PDUFA) date of July 30, 2009. Under this revised timeline, Transcept now anticipates action from the FDA on the NDA on or before October 31, 2009.
News of the day
Hospitals May Strike Deal To Save $200 Billion
Hospitals could sign on to an agreement with Senate health reform leader Max Baucus, D-Mont., and the White House to help save up to $200 billion as part of the overhaul plan, lobbyist and health industry s tell Roll Call. The possible deal would come on the heels of an agreement between the drug industry lobbying group, Pharmaceutical Research and Manufacturers of America and senior Democrats to save $80 billion over 10 years by expanding the Medicare drug program. The American Hospital Association, the Federation of American Hospitals and the Catholic Health Association are all said to be in talks about the potential bargain.
Public Health

Seminar Series Looks At Women's Health In The 21st Century

A series of free seminars, one in Belfast, has been organised to raise awareness of women"s health and rights in a 21st century where new biomedical techniques allow surrogate motherhood, test-tube babies, organ transplants and other medical developments. The series of four events begins on 27 May with a day-long workshop at the University of Warwick which looks at governance - the ways that health treatments and procedures have regulated women"s lives and how women have responded. The seminar will examine the benefits and harm of such treatments. The feminist movement in the 20th century looked at medical treatments in terms of women having legal and personal rights over their own bodies. The Warwick seminar on governance looks more at how the latest biomedical developments affect their sense of self. The speakers are Professor Mary Rawlinson of Stony Brook University, US, Professor Emily Jackson, of the London School of Economics, and Professor Sally Sheldon, of the University of Kent. Other events in the series include a seminar on 9 -11 September at Queen"s University Belfast, looking at the significance for women of the latest medical procedures concerned with disabilities and ageing. Two other events are planned for 2010, to be held at the universities of Lancaster and Liverpool in January and September. The event series, which is funded by the Economic and Social Research Council and is entitled "Retheorising Women"s Health: Shifting Paradigms and the Biomedical Body", is not only for academics but also for nurses and doctors and others interested in the issues. All the events are free, and some places still remain. Contact Professor Deborah Lynn Steinberg at D.L.Steinberg@warwick.ac.uk regarding the Warwick event and Dr Azrini Wahidin regarding the Belfast event, at a.wahidin@qub.ac.uk The Belfast event also includes a one-day conference on the rights of people with disabilities, organised in honour of the late Professor Eithne McLaughlin, who worked at Queen"s in this field. The British Sociological Association"s mission is to represent the intellectual and sociological interests of its members. British Sociological Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):